Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 15,800
+950 (6.40%)
Aug 12, 2026, 3:30 PM KST
156.91% (1Y)
| Market Cap | 674.31B +147.8% |
| Revenue (ttm) | 67.20B +196.2% |
| Net Income | 20.33B |
| EPS | 441.04 |
| Shares Out | 45.41M |
| PE Ratio | 33.67 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,635,516 |
| Open | 14,610 |
| Previous Close | 14,850 |
| Day's Range | 13,920 - 15,840 |
| 52-Week Range | 5,663 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 20, 2026 |